Schedule 13G ownership disclosure

TG THERAPEUTICS INC COM

Security class unavailable · CUSIP: 88322Q108

Event date: 2023-03-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,451,241
Percent of class
7.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-002440
Form type
SC 13G
Filer
Darwin Global Management, Ltd.
CIK
CIK 1839209
Filed
Apr 03, 2023
Reporting period
Mar 22, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub